Different immunological effects of the molecular targeted agents sunitinib, everolimus and temsirolimus in patients with renal cell carcinomaYukari Kobayashi(Kindai University), Kazuhiro Kakimi(Kindai University Hospital)International Journal of OncologyFebruary 4, 202010.3892/ijo.2020.4975Cited by 13SaveCiteExport RISWatch citationsRelated PapersDenatured Mammalian Protein Mixtures Exhibit Unusually High Solubility in Nucleic Acid-Free Pure Water|PLoS ONE|2014|11